The efficacy and safety of early supplementation of iron polymaltose complex in preterm infants

American Journal of Perinatology

Volumn 24, Issue 2, 2007, Pages 95-99

  Arnon, Shmuel ^a,b   Shiff, Yakov ^c   Litmanovitz, Ita ^a,b   Regev, Rivka H ^a,b   Bauer, Sofia ^a   Shainkin Kestenbaum, Ruth ^a   Bental, Yoram ^c,d   Dolfin, Tzipora ^a,b  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c LANIADO HOSPITAL   (Israel)

^d TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Iron polymaltose complex; Iron supplementation; Morbidities associated with prematurity; Preterm infants

Indexed keywords

ALPHA TOCOPHEROL; FERRITIN; HEMOGLOBIN; IRON; IRON POLYMALTOSE; TRANSFERRIN RECEPTOR;

ARTICLE; BREAST MILK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIETARY INTAKE; DRUG EFFICACY; DRUG SAFETY; EARLY INTERVENTION; ENTERIC FEEDING; ERYTHROCYTE TRANSFUSION; FEMALE; GESTATIONAL AGE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFANT; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PREMATURITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RETICULOCYTE;

DIETARY SUPPLEMENTS; ERYTHROCYTE TRANSFUSION; FEMALE; FERRIC COMPOUNDS; GLYCOPROTEINS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; PROSPECTIVE STUDIES;

EID: 33847687768     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-970179     Document Type: Article

References (19)

1. Roth P. Anemia in preterm infants. Pediatr Rev 1996;17:370
2. American Academy of Pediatrics Committee on Nutrition. Nutritional needs of low-birth-weight infants. Pediatrics 1985;75:976-986
3. Franz AR, Mihatsch WA, Sander S, Kron M, Pohlandt F. Prospective randomized trial of early versus late enteral iron supplementation in infants with a birth weight of less than 1301 grams. Pediatrics 2000;106:700-706
4. Inder TE, Clemett RS, Austin NC, Graham P, Darlow BA. High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity. J Pediatr 1997;131:541-544
5. Tuomainen TP, Nyyssonen K, Porkkala-Sarataho E, et al. Oral supplementation with ferrous sulfate but not with non-ionic iron polymaltose complex increase the susceptibility of plasma lipoproteins to oxidation. Nutr Res 1999;19:1121-1132
6. Franz AR, Pohlandt F. Red blood cell transfusions in very and extremely low birthweight infants under restrictive transfusion guidelines: is exogenous erythropoietin necessary? Arch Dis Child Fetal Neonatal Ed 2001;84:F96-F100
7. Jew RK, Owen D, Kaufman D, Balmer D. Osmolarity of commonly used medications and formulas in the neonatal intensive care unit. Nutr Clin Pract 1997;12:158-163
8. Sweet DG, Savage GA, Tubman R, Lappin TR, Halliday HL. Cord blood transferrin receptors to assess fetal iron status. Arch Dis Child Fetal Neonatal Ed 2001;85:F46-F48
9. Lundstrom U, Siimes MA, Dallman PR. At what age does iron supplementation become necessary in low-birth-weight infants? J Pediatr 1977;91:878-883
10. Hall RT, Wheeler RE, Benson J, Harris G, Rippetoe L. Feeding iron-fortified premature formula during initial hospitalization to infants less than 1800 grams birth weight. Pediatrics 1993;92:409-414
11. Rao R, Georgieff M. Microminerals. In: Tsang RC, Uauy R, Koletzko B, Zlotkin S, eds. Nutrition of the Preterm Infant: Scientific Basis and Practical Guidelines. 2nd ed. Cincinnati, OH: Digital Educational Publishing; 2005:271-288
12. Turker G, Sarper N, Gokalp AS, Usluer H. The effect of early recombinant erythropoietin and enteral iron supplementation on blood transfusion in preterm infants. Am J Perinatol 2005;22:449-455
13. Rudzinska IM, Kornacka MK, Pawluch R. Treatment with human recombinant erythropoietin and frequency of retinopathy of prematurity. Przegl Lek 2002;59(suppl 1):83-85
14. Ohlsson A, Aher S. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev 2006;(19):CD004863
15. Johnson G, Jacobs P. unavailability and the mechanisms of intestinal absorption of iron from ferrous ascorbate and ferric polymaltose in experimental animals. Exp Hematol 1990;18:1064-1069
16. Erichsen K, Ulvik RJ, Grimstad T, Berstad A, Berge RK, Hausken T. Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2005;22:831-838
17. Buonocore G, Perrone S, Bracci R. Free radicals and brain damage in the newborn. Biol Neonate 2001;79:180-186
18. Kuiper-Kramer EP, Baerts W, Bakker R, van Eyck J, van Raan J, van Eijk HG. Evaluation of the iron status of the newborn by soluble transferrin receptors in serum. Clin Chem Lab Med 1998;36:17-21
19. Melhorn DK, Gross S. Vitamin E-dependent anemia in the premature infant. I. Effects of large doses of medicinal iron. J Pediatr 1971;79:569-580